Public trial registry of the CCC-Munich

Trial AMG 562 20170533

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AMG 562 20170533
World
Full title
:

Eine offene Phase-1-Studie am Menschen, in der Sicherheit, Verträglichkeit,
Pharmakokinetik und Wirksamkeit von AMG 562 bei Patienten mit rezidiviertem / refraktärem Diffus
Großes B-Zell-Lymphom, Mantelzell-Lymphom oder follikuläres Lymphom

World
EudraCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551 Lmu
Indications
Classification Code Description
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Trial type
:
Interventional
World
Phase
:
I
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.